• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT SUPERA SELF-EXPANDING STENT SYSTEM; SELF EXPANDING STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT SUPERA SELF-EXPANDING STENT SYSTEM; SELF EXPANDING STENT SYSTEM Back to Search Results
Catalog Number S-45-080-120-P6
Device Problems Entrapment of Device (1212); Difficult to Remove (1528); Device Damaged by Another Device (2915); Activation Failure (3270)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 11/20/2018
Event Type  Injury  
Manufacturer Narrative
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.It is unknown if the device is returning for analysis.A follow up report will be submitted with all additional relevant information.
 
Event Description
It was reported that the procedure was performed to treat a moderately calcified lesion in the left proximal popliteal and left superficial femoral artery.A supera stent was implanted without issue.A second supera self-expanding stent system was then advanced to deploy the stent proximally to the previously implanted stent; however, [during deployment] the supera stent overlapped the previously implanted stent due to the stent size and both stents became caught and were pulled back.The stents released from each other and the supera sheath was attempted to be pulled back; however, the supera stent had not been properly pushed out [fully deployed] from the delivery system and the stent was dragged across the bifurcation during device removal.The patient was then taken to surgery, and a surgical cut down was performed to remove the stent from the right iliac.The first deployed supera stent remained in the target lesion.The procedure concluded after the surgical cut down and no additional treatment was provided for the target lesion.There was no adverse patient sequela and no reported clinically significant delay in the procedure.No additional information was provided.
 
Manufacturer Narrative
Device codes: 2915 labeled.Internal file number - (b)(4).Evaluation summary: a visual inspection was performed on the returned device.The reported failure to deploy, entrapment of device, difficulty to remove and device damaged by another device (caused damage) was unable to be replicated in a testing environment as it was based on operational circumstances.A review of the lot history record revealed no manufacturing nonconformities that would have contributed to this complaint.Additionally, a review of the complaint history of the reported lot revealed no other similar incidents reported for this lot.The investigation determined the reported difficulties and treatment appear to be related to circumstances of the procedure.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.
 
Event Description
Subsequent to the initially filed report, the following information was received: the implanted stent was a 4.5x120mm supera.The second stent used was a 4.5x80mm supera.The second supera stent pulled back the previously implanted supera stent from the target lesion.Both stents were surgically removed from the patient.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUPERA SELF-EXPANDING STENT SYSTEM
Type of Device
SELF EXPANDING STENT SYSTEM
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
MDR Report Key8176246
MDR Text Key130773485
Report Number2024168-2018-09824
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
PMA/PMN Number
P120020
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Remedial Action Other
Type of Report Initial,Followup
Report Date 02/06/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/18/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/30/2020
Device Catalogue NumberS-45-080-120-P6
Device Lot Number8071761
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/09/2019
Date Manufacturer Received01/30/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
STENT: SUPERA
Patient Outcome(s) Required Intervention;
Patient Age49 YR
-
-